Cargando…
Enhanced glutamine utilization mediated by SLC1A5 and GPT2 is an essential metabolic feature of colorectal signet ring cell carcinoma with therapeutic potential
BACKGROUND: Colorectal signet-ring cell carcinoma (SRCC) is characterized as a rare subset of colorectal cancer with extremely poor prognosis and it is known to have low or negative (18)F fluorodeoxyglucose ((18)F-FDG) uptake. To date, no in-depth study revealing the metabolic features of colorectal...
Autores principales: | Wang, Renjie, Xiang, Wenqiang, Xu, Ye, Han, Lingyu, Li, Qingguo, Dai, Weixing, Cai, Guoxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186745/ https://www.ncbi.nlm.nih.gov/pubmed/32355746 http://dx.doi.org/10.21037/atm.2020.03.31 |
Ejemplares similares
-
Systematic analysis of glutamine metabolism family genes and exploration of the biological role of GPT in colorectal cancer
por: Dai, Weiqi, et al.
Publicado: (2023) -
Development and external validation of a predictive scoring system associated with metastasis of T1‐2 colorectal tumors to lymph nodes
por: Mo, Shaobo, et al.
Publicado: (2020) -
Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer
por: Zhou, Zheng, et al.
Publicado: (2019) -
PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
por: Dai, Weixing, et al.
Publicado: (2022) -
Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer
por: Mo, Shaobo, et al.
Publicado: (2020)